Astera Labs vs. Arm: Which Technology Stock Is a Better Buy in 2026?

As artificial intelligence demands higher performance, investors are weighing the explosive growth of Astera Labs (NASDAQ:ALAB) against the architectural dominance of Arm (NASDAQ:ARM) to find the superior long-term play.

While both companies are essential to the modern computing ecosystem, they occupy different niches. Astera Labs focuses on the physical connections that keep data flowing, while Arm licenses the blueprints for the processors themselves. This comparison helps you decide which business model fits your strategy in a rapidly changing market.

The case for Astera Labs

Astera Labs is a high-growth player among semiconductor stocks, providing hardware that eliminates bottlenecks in AI data centers. The company offers semiconductor-based connectivity solutions paired with its COSMOS software to help hyperscalers manage complex workloads. Customer concentration like this adds a layer of risk to the business, as the top three clients accounted for roughly 86% of total revenue in 2025.

In the fiscal year ended Dec. 31, 2025, revenue reached approximately $852.5 million. This represents an increase of nearly 115.1% compared with the prior fiscal year. The company reported a net income of nearly $219.1 million, marking a major turnaround from the net loss it reported in the previous year.

As of its December 2025 balance sheet, the debt-to-equity ratio is approximately 0.0x. This ratio measures total debt relative to shareholder equity, indicating that the company carries minimal debt. The current ratio is roughly 10.2x, indicating a strong ability to cover short-term liabilities with current assets.

Free cash flow was close to $281.8 million for the year. Note that stock-based compensation accounted for roughly 50.1% of operating cash flow, inflating reported cash generation, since SBC is a non-cash expense added back in the cash flow statement.

The case for Arm

ARM licenses its highly efficient processor architecture to a vast ecosystem of chip designers and device manufacturers. Its intellectual property is a foundational component of everything from mobile phones to the world’s most advanced AI servers. The company relies on a recurring revenue model based on licensing fees and royalties paid by partners such as Apple.

In the fiscal year ended March 31, 2026, revenue reached nearly $4.9 billion. This marks a growth rate of roughly 22.8% compared with the prior fiscal year. Arm generated a net income of approximately $904.0 million, demonstrating its ability to scale its licensing business while maintaining strong bottom-line performance.

As of its June 2026 balance sheet, the debt-to-equity ratio was approximately 0.0x. This indicates a very low reliance on debt compared to shareholder equity. The current ratio is close to 5.3x, providing a strong buffer for meeting near-term financial obligations.

Trailing free cash flow through the fiscal first quarter ending in June reached roughly $1.5 billion, indicating its profitability continues to improve. Note that stock-based compensation accounted for roughly 69.0% of operating cash flow, inflating reported cash generation, since SBC is a non-cash expense added back in the cash flow statement.

Risk profile comparison

Astera Labs faces significant risk from its narrow customer base, where the loss of one hyperscaler could cause revenue to plummet. The company also relies heavily on Taiwan Semiconductor for manufacturing, exposing it to potential supply chain shocks or geopolitical instability in East Asia. Intense competition from larger rivals like Broadcom could also pressure its market share and pricing power.

ARM faces competitive pressure from the open-source RISC-V architecture, which provides a free alternative to its proprietary licensing model. Large customers such as Alphabet may eventually develop their own instruction sets to reduce their dependence on ARM designs. Additionally, the company maintains significant exposure to the Chinese market, where regulatory changes or trade restrictions could impact its future royalty revenue.

Valuation comparison

While both companies trade at premium multiples, Astera Labs appears cheaper on a price-to-sales basis, while Arm commands a higher valuation based on future earnings estimates.

Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.

Which stock would I buy in 2026?

ARM enjoys a dominant position in its market, where its chip designs are used in virtually every smartphone and increasingly in AI servers. Astera Labs is well-positioned to see strong revenue growth due to the shortage of compute capacity to meet AI demand. Because both companies face similar risks and trade at similarly elevated multiples of sales and forward earnings, I would buy Astera Labs right now.

Astera Labs is doubling its revenue year over year, whereas Arm is growing at a slower rate of around 25%. This shows that Astera may have more upside if AI infrastructure spending remains strong.

Another catalyst working in Astera’s favor is expanding margins. Operating profit exploded over the last few years, growing 546% year over year on a trailing-12-month basis to $273 million. It should continue to see improving margins as it expands its customer base and supplies purpose-built solutions for customers’ specific workloads.

Overall, both stocks have similar profiles from a valuation and risk perspective. Both are also trading off their recent highs. I believe Astera may offer greater upside over the next few years, given its stronger growth trajectory and margin expansion opportunities.

John Ballard has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Apple, Arm Holdings, Broadcom, and Taiwan Semiconductor Manufacturing. The Motley Fool recommends Astera Labs. The Motley Fool has a disclosure policy.